<unk> (injection) is a topoisomerase I inhibitor that is FDA approved for the treatment of small cell lung cancer, stage IV-B, recurrent, or persistent carcinoma of the cervix. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include bleeding, anaphylactoid reactions, abdominal pain, Interstitial lung disease, and pruritus.
Topotecan 
Ifosfamide
Mafosfamide
Zorubicin
Etoposide 
Vincristine sulfate
Idoxuridine
Semustine